Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Recursion Pharmaceuticals Inc (RXRX) vs Vanguard Total Stock Market Index Fund ETF (VTI) Price & Performance

Recursion Pharmaceuticals IncTrade
Vanguard Total Stock Market Index Fund ETFTrade

Price performance (Past 24H)

Key statistics

Recursion Pharmaceuticals Inc vs Vanguard Total Stock Market Index Fund ETF — how do they compare? Recursion Pharmaceuticals Inc trades at $3.37 (market cap $1.81B), while Vanguard Total Stock Market Index Fund ETF trades at $382. The key difference: Vanguard Total Stock Market Index Fund ETF is trading nearer its 52-week high, Recursion Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.

RXRXVTI
Market Cap
$1.81B
Sector
Health
52-Week High
$6.79$381.78
52-Week Low
$2.84$311.68
Enterprise Value
$1.33B

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Recursion Pharmaceuticals Inc

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.

Read more on RXRX

About Vanguard Total Stock Market Index Fund ETF

The fund employs an indexing investment approach designed to track the performance of the index, which represents approximately 100% of the investable US stock market and includes large-, mid-, small-, and micro-cap stocks. It invests by sampling the index, meaning that it holds a broadly diversified collection of securities that, in the aggregate, approximates the full index in terms of key characteristics.

Read more on VTI